Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing advanced-stage cervical cancer.

D Allen1, K Narayan

  • 1Department of Gynaecological Oncology, Mercy Hospital for Women, University of Melbourne, Clarendon Street, East Melbourne, Vic. 3002, Australia. dallen@mercy.com.au

Best Practice & Research. Clinical Obstetrics & Gynaecology
|September 10, 2005
PubMed
Summary

Accurate staging for advanced cervical cancer is crucial for effective treatment planning. Current methods are limited, necessitating improved approaches using imaging and surgical pathology to enhance patient survival and minimize treatment side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring and Modeling Population Exposures to Air Pollutants from Oil and Gas Development: Part 1. Predictive, Source-Oriented Modeling and Measurements to Evaluate Community Exposures to Air Pollutants and Noise from Unconventional Oil and Gas Development.

Research report (Health Effects Institute)·2026
Same author

Policies, processes, and principles of informed consent in radiotherapy for gynaecological cancers: A UK national survey.

Radiography (London, England : 1995)·2026
Same author

Editorial Expression of Concern: The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.

Nature·2026
Same author

Effects of methane inhibitors on ruminal fermentation and microbial composition in vitro using inoculum from phenotypically high- and low-enteric-methane-emitting cows.

Journal of dairy science·2025
Same author

Endoscopic combined intrarenal surgery (ECIRS) versus supine percutaneous nephrolithotomy (S-PCNL): a propensity score matched study of surgical outcomes and complications.

World journal of urology·2025
Same author

Screening macroalgae for mitigation of enteric methane in vitro.

Scientific reports·2023

Area of Science:

  • Oncology
  • Medical Imaging
  • Gynecologic Oncology

Background:

  • Current staging systems for advanced cervical cancer, including the International Federation of Gynaecology and Obstetrics (FIGO) system, have limitations in accuracy.
  • Inaccurate staging hinders optimal treatment planning and can lead to suboptimal patient outcomes.

Purpose of the Study:

  • To discuss the limitations of current cervical cancer staging methods.
  • To explore the potential of advanced imaging techniques and surgical pathology for more accurate disease assessment.
  • To highlight the need for improved prognostic grouping in advanced cervical cancer management.

Main Methods:

  • Review of existing clinical staging systems for cervical cancer.
  • Discussion of the role of surgical pathology in tumor characterization.

Related Experiment Videos

  • Exploration of the capabilities of modern non-invasive imaging technologies.

    • Main Results:

    • The clinical FIGO staging system for cervical cancer is identified as inaccurate, impacting treatment decisions.
    • Advanced imaging techniques offer a non-invasive means to obtain crucial surgicopathological information.
    • Optimized categorization of prognostic groups is essential for improved patient management.

    Conclusions:

    • There is a critical need to refine the staging and definition of advanced cervical cancer.
    • Integrating advanced imaging and pathological data can lead to more precise disease delineation.
    • Improved staging accuracy promises to minimize treatment morbidity and enhance survival rates in advanced cervical cancer patients.